Waystar Holding Corp. (NASDAQ:WAY) is one of the best digital health stocks to buy now.
On October 30, 2025, following the company’s third-quarter earnings, Mizuho Securities lifted its target from $48 to $50 and reiterated an Outperform rating, citing strong demand for Waystar’s revenue cycle management solutions. The firm highlighted that adoption of AI-driven claims denial tools was a key contributor to the company’s above-consensus performance.
Waystar Holding Corp. (NASDAQ:WAY) released their Q3 report on October 29, 2025. Double-digit growth came from steady transaction volume, expanding client adoption, and early Iodine Software cross-sell, which lifted revenue 12% to $268.7M and kept adjusted EBITDA strong at $112.7M with a 42% margin. Cost discipline and scale did the rest,…



